Thoracoabdominal aortic aneurysm in connective tissue disorder patients
- PMID: 35463710
- PMCID: PMC8980973
- DOI: 10.1007/s12055-021-01324-9
Thoracoabdominal aortic aneurysm in connective tissue disorder patients
Abstract
Connective tissue disorders (CTDs) are a group of genetically triggered diseases in which the primary defect involves collagen and elastin protein assembly with potential vascular degenerations such as thoracoabdominal aortic aneurysm (TAAA) and dissection. These most commonly include Marfan syndrome, Ehlers-Danlos syndrome, Loeys-Dietz syndrome, and familial thoracic aortic aneurysm and dissection. Open surgical repair represents the standard approach in this specific group of patients. Extensive aortic replacements are generally performed in order to reduce long-term complications caused by the progressive dilatation of the remnant aortic segments. In the last decades, endovascular interventions have emerged as a valid alternative in patients affected by degenerative TAAA. However, in patients with CTD, this approach presents higher rates of reinterventions and postoperative complications with a disputable long-term durability, and it is nowadays performed for very selective indications such as severe comorbidities and urgent/emergent settings. Despite a deeper knowledge of the pathophysiological mechanisms involved in CTD, improvements in medical therapy, and a multidisciplinary approach fully involved in the management of these usually frailer patients, this specific group still represents a challenge. Further dedicated studies addressing mid-term and long-term outcomes in this selected population are needed.
Keywords: Aortic dissection; Connective tissue disorder; Ehlers-Danlos syndrome; Loeys-Dietz syndrome; Marfan syndrome; Thoracoabdominal aortic aneurysm.
© Indian Association of Cardiovascular-Thoracic Surgeons 2022.
Conflict of interest statement
Conflict of interestNone.
Figures






Similar articles
-
Outcomes of descending and thoracoabdominal aortic repair in connective tissue disorder patients.Scand Cardiovasc J. 2022 Dec;56(1):352-359. doi: 10.1080/14017431.2022.2125174. Scand Cardiovasc J. 2022. PMID: 36151718
-
Connective tissue disease type mediates branch patency of grafts in open thoracoabdominal aortic reconstruction.J Vasc Surg. 2022 Jan;75(1):90-98. doi: 10.1016/j.jvs.2021.05.062. Epub 2021 Jun 26. J Vasc Surg. 2022. PMID: 34186165 Free PMC article.
-
Outcomes of Thoracic Endovascular Aneurysm Repair (TEVAR) in Patients With Connective Tissue Disorders.Vasc Endovascular Surg. 2020 Nov;54(8):676-680. doi: 10.1177/1538574420945070. Epub 2020 Jul 30. Vasc Endovascular Surg. 2020. PMID: 32729398
-
Treatment of thoracoabdominal aortic disease in patients with connective tissue disorders.J Vasc Surg. 2018 Oct;68(4):1257-1267. doi: 10.1016/j.jvs.2018.06.199. J Vasc Surg. 2018. PMID: 30244929 Review.
-
Thoracic Aortic Aneurysm: A Clinical Review.Cardiol Clin. 2021 Nov;39(4):505-515. doi: 10.1016/j.ccl.2021.06.003. Cardiol Clin. 2021. PMID: 34686263 Review.
Cited by
-
Promising Novel Therapies in the Treatment of Aortic and Visceral Aneurysms.J Clin Med. 2023 Sep 10;12(18):5878. doi: 10.3390/jcm12185878. J Clin Med. 2023. PMID: 37762818 Free PMC article. Review.
-
Olfactory Receptors and Aortic Aneurysm: Review of Disease Pathways.J Clin Med. 2024 Dec 19;13(24):7778. doi: 10.3390/jcm13247778. J Clin Med. 2024. PMID: 39768700 Free PMC article. Review.
-
Outcomes following Management of Complex Thoracoabdominal Aneurysm by an Open Approach.J Clin Med. 2023 Apr 29;12(9):3193. doi: 10.3390/jcm12093193. J Clin Med. 2023. PMID: 37176634 Free PMC article.
References
LinkOut - more resources
Full Text Sources